Raising a child requires attending to their needs as vulnerable beings. This
includes feeding, sheltering, nurturing, and protecting them from harm. There
are many dangers in the world and one serious hazard is disease. Humans are
resilient and intelligent creatures; and will go to great lengths to ensure the
survival of our species. Pathogens such as viruses are capable of mass
extinction and this threat has motivated humans to create a protection against
these virulent microorganisms. Viruses evolve more rapidly than humans and
although the immune system is adaptable, people are not born with an inert
protection against viruses. In fact, children are the most defenseless against
viral infection. People are typically vaccinated before they are able to consent
and on rare occasion vaccines have been reported to be more harmful than
helpful. Despite the risk of adverse side effects, vaccines have saved
generations of children from debilitating and deadly diseases.
Immunization is the process whereby a person is made resistant to an infectious
disease, typically by the administration of a vaccine. Vaccines stimulate the
body’s own immune system to protect the person against subsequent infection or
disease. Immunization is a proven tool for controlling and eliminating
life-threatening infectious diseases and is estimated to prevent between 2 and 3
million deaths each year. It is one of the most cost-effective health
investments, with proven strategies that make it accessible to even the most
remote and vulnerable populations. In the United States, it is required that
children have 36 vaccinations to enroll in public or private schools and most
are administered before the child is 12 months old. These include Diphtheria,
Tetanus, Polio, Haemophilus influenzae Type B, Hepatitis A and B, Measles,
Mumps, Rubella, Meningoccocal, Pheumonococcal, and Varicella.
Vaccines contain many ingredients that make them safe and effective, including
preservatives, adjuvants, and other ingredients. Thimerosal is a
mercury-containing preservative used in some vaccines and other products since
the 1930s and is very effective in preventing bacterial contamination of the
vaccine liquid. Understandably, some people believed that the mercury in
thimerosal was harmful. The most extreme opponents of thimerosal believed it was
the cause of their childrens’ autism, despite the lack of scientific evidence
supporting the notion. In July 1999, the Public Health Service agencies, the
American Academy of Pediatrics, and vaccine manufacturers agreed that thimerosal
should be reduced or eliminated in vaccines as a precautionary measure.
Since
that time, studies have found that there is no convincing scientific evidence
that the low doses of thimerosal in vaccines causes harm, except for minor
reactions like redness and swelling at the injection site. Since 2001, with the
exception of some influenza vaccines, thimerosal is not used as a preservative
in routinely recommended childhood vaccines. Yet, the rates of disorders
speculated to be caused by these ingredients, such as autism, have not gone
down.
Autism leads to considerable difficulties for the families of these patients
because many of them remain dependent throughout their lives. Special education
costs can exceed $30,000 per year. The annual cost of care in a public school
may be as much as $80,000-100,000. Children with autism require around-the-clock
care, and parents of these special children report a challenge in finding
knowledgeable and sympathetic health care providers. There are also challenges
in finding reliable and valid information about autism etiology, treatment, and
prognosis. Parents also report frustration in seeing their child change from
being active and engaged to being apathetic and nonresponsive. Parents blame
vaccine administration for the onset of these symptoms.
Given the lack of direct evidence for a biological mechanism and the fact that
all well-designed epidemiological studies conclude that there is no causation
between thimerosal and autism, the literature recommends that cost-benefit
assessments regarding the use of thimerosal-containing vaccines versus
thimerosal-free vaccines and other biological or pharmaceutical products,
whether in the United States or other countries, should not include autism as a
potential risk.
Another ingredient of vaccines is aluminum salts, which help create a better
immune response and decreases the number of doses for protection. Everyone is
exposed to mass amounts of aluminum in the earth’s crust; it’s present in our
food, air and water, including breast milk and formula. Aluminum has been used
and studied in vaccines for 75 years and is safe. Parents should be reassured
that quantities of mercury, aluminum, and formaldehyde contained in vaccines are
likely to be harmless on the basis of exposure studies in humans or experimental
studies in animals. Although severe anaphylactic reactions may occur rarely
after receipt of vaccines that contain sufficient quantities of egg proteins (ie
influenza) or gelatin (ie, MMRII), children who are at risk for severe infection
with influenza can be desensitized to influenza vaccine, and gelatin-specific
allergies are very rare. Immediate-type hypersensitivity reactions to neomycin
or yeast proteins have not been clearly documented and remain theoretical.
Public paranoia over the perceived risks of vaccines has increased despite
advances in vaccine safety. Social media, such as the Internet, provides an easy
way to obtain information regardless of its reliability and many sources present
opinions as facts. Such is the case with celebrity opponents like Jenny McCarthy
who proliferate the anti-vaccine message. Vaccine fear is also expressed as the
social anxiety over technology and modernization. There is much distrust over
poorly managed health risk issues making it more difficult for governments to
facilitate trust. There is also a skeptical view of the financially motivated
pharmaceutical companies. Despite these issues, there needs to be more emphasis
on education and the factual basis of such theories. There is a complex and
deeply rooted culture of vaccination-resistance in this country. It is important
for physical therapists and all health care providers to recognize these
anxieties and respond to them with evidence in both the public and clinical
encounter. Vaccination’s goal of disease prevention must be the primary message
to the public. Health care professionals need to address patient concerns about
vaccine safety with tolerance and respect. This includes the willingness to
provide detailed information about both the risks and benefits of vaccination.
Last revised: October 15, 2011
by Erica Cannizzo, DPT
References:
1) Immunization Safety Review: Vaccines and Autism.
Institute of Medicine, The National Academies Press: 2004
2) Thompson, et al. Infant and Environmental Exposures to Thimerosal and
Neuropsychological Outcomes at Ages 7 to 10 Years. New England Journal of
Medicine. 2007; 357:1281-1292
3) Stehr-Green, P. Autism and Thimerosal-Containing Vaccines: Lack of
Consistent Evidence for an Association. American Journal of Preventive
Medicine. 2003; 25:101-106.
4) Schechter and Grether. Continuing increases in autism reported to
California's developmental services system: mercury in retrograde. Archives
of General Psychiatry. 2008; 65(1):19-24
5) Pichichero, et al. Mercury Levels in Newborns and Infants After Receipt
of Thimerosal-Containing Vaccines Pediatrics. 2008;121(2), 208-214
6) Nelson KB, Bauman ML. Thimerosal and autism? Pediatrics. 2003;111:674-679
7) Baylor NW, Egan W, Richman P. Aluminum salts in vaccines—U.S.
perspective. Vaccine 2002; 20: S18-S23.
8) Heron et al. Thimerosal Exposure in Infants and Developmental Disorders:
A Prospective Cohort Study in the United Kingdom Does Not Support a Causal
Association, Pediatrics. Vol. 114 No. 3, 2004, pp. 577-583
9) Baird G et al. Measles Vaccination and Antibody Response in Autism
Spectrum Disorders. Archives of Disease in Childhood 2008; 93(10):832-7
10) Uchiyama T et al. MMR-Vaccine and Regression in Autism Spectrum
Disorders: Negative Results Presented from Japan Journal of Autism and
Developmental Disorders, 2007; 37(2):210-7
11) D’Souza Y et al. No Evidence of Persisting Measles Virus in Peripheral
Blood Mononuclear Cells from Children with Autism Spectrum Disorder
Pediatrics 2006; 118(4):1664-75
12) Doja A, Roberts W. Immunizations and Autism: A Review of the Literature.
The Canadian Journal of Neurological Sciences 2006; 33(4):341-6
13) Fombonne E et al. Pervasive Developmental Disorders in Montreal and
Quebec, Canada: Prevalence and Links with Immunizations. Pediatrics. 2006;
118(1):e139-50
14) Honda H et al. No effect of MMR withdrawal on the incidence of autism: a
total population study, Journal of Child Psychology and Psychiatry 2005
June; 46(6):572-9
15) Thompson, et al. Early Thimerosal Exposure and Neuropsychological
Outcomes at 7 to 10 Years. New England Journal of Medicine. 2007;
357:1281-1292
16) Stehr-Green P et al. Autism and thimerosal-containing vaccines: Lack of
consistent evidence for an association. American Journal of Preventive
Medicine. 2003; 25(2):101-6
17) DeStefano F et al. Age at First Measles-Mumps-Rubella Vaccination in
Children with Autism and School-Matched Control Subjects: A Population-Based
Study in Metropolitan Atlanta Pediatrics 2004; 113(2): 259-66.
18) Smeeth L et al. MMR Vaccination and Pervasive Developmental Disorders: A
Case-Control Study Lancet 2004; 364(9438):963-9
19) Makela A et al. Neurologic Disorders after Measles-Mumps-Rubella
Vaccination Pediatrics. 2002; 110:957-63
20) Black C et al. Relation of Childhood Gastrointestinal Disorders to
Autism: Nested Case Control Study Using Data from the UK General Practice
Research Database British Medical Journal. 2002; 325:419-21
21) Taylor B et al. Measles, Mumps, and Rubella Vaccination and Bowel
Problems or Developmental Regression in Children with Autism: Population
Study. British Medical Journal. 2002; 324(7334):393-6
22) Fombonne E et al. No Evidence for a New Variant of
Measles-Mumps-Rubella-Induced Autism Pediatrics. 2001;108(4):58
23) Dales L et al. Time Trends in Autism and in MMR Immunization
Coverage in California. Journal of the American Medical Association. 2001;
285(9):1183-5
24) Afzal MA, et al. Further Evidence of the Absence of Measles Virus Genome
Sequence in Full Thickness Intestinal Specimens from Patients with Crohn’s
Disease Journal of Medical Virology. 2000; 62(3):377-82
25) Madsen et al. Thimerosal and the Occurrence of Autism: Negative
Ecological Evidence From Danish Population-Based Data. Pediatrics. 2003;
112(3) 2003 604-606
26) Mills E et al. Systematic review of qualitative studies exploring
parental beliefs and attitudes towards childhood vaccination identifies
barriers to vaccination. Journal of Clinical Epidemiology. 2005; 58(11);
1081-1088